Hainan Shuangcheng Pharmaceuticals Co., Ltd. (SHE:002693)

SHE:002693 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 29, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Market Capitalization	3,558	2,886	7,601	3,129	3,015	1,945
Market Cap Growth	-1.15%	-62.03%	142.94%	3.77%	55.05%	10.89%
Enterprise Value	3,721	3,136	7,793	3,255	3,130	2,127
Last Close Price	8.58	6.96	18.33	7.51	7.27	4.72
PE Ratio	171.60	151.56	-	-	334.55	-
Forward PE	-	18.69	18.69	18.69	18.69	18.69
PS Ratio	12.86	10.43	43.63	13.26	10.97	6.07
PB Ratio	8.46	6.86	18.47	6.04	5.19	3.43
P/TBV Ratio	11.57	9.38	22.66	7.47	6.83	4.83
P/FCF Ratio	201.27	163.27	-	-	-	-
P/OCF Ratio	58.38	47.36	-	268.82	119.56	82.56
EV/Sales Ratio	13.44	11.33	44.73	13.80	11.39	6.64
EV/EBITDA Ratio	48.28	40.69	-	205.51	235.43	451.32
EV/EBIT Ratio	154.62	130.31	-	-	-	-
EV/FCF Ratio	210.47	177.38	-	-	-	-
Debt / Equity Ratio	0.51	0.51	0.67	0.36	0.38	0.31
Debt / EBITDA Ratio	2.77	2.77	-	11.75	16.80	37.71
Debt / FCF Ratio	12.09	12.09	-	-	-	-
Net Debt / Equity Ratio	0.37	0.37	0.56	0.30	0.13	0.18
Net Debt / EBITDA Ratio	2.01	2.01	-11.89	9.73	5.82	21.36
Net Debt / FCF Ratio	8.75	8.75	-3.52	-4.10	-9.96	-12.45
Asset Turnover	0.34	0.34	0.22	0.28	0.31	0.36
Inventory Turnover	1.71	1.71	1.09	1.18	1.57	1.62
Quick Ratio	0.45	0.45	0.41	0.43	0.58	1.01
Current Ratio	0.67	0.67	0.88	0.97	0.79	1.53
Return on Equity (ROE)	2.14%	2.14%	-22.87%	-13.10%	-1.48%	-7.00%
Return on Assets (ROA)	1.87%	1.87%	-5.65%	-2.69%	-3.13%	-3.52%
Return on Invested Capital (ROIC)	3.96%	3.95%	-10.92%	-5.54%	-6.67%	-7.15%
Return on Capital Employed (ROCE)	4.60%	4.60%	-11.80%	-5.60%	-7.50%	-6.60%
Earnings Yield	0.54%	0.66%	-1.03%	-1.62%	0.30%	-1.04%
FCF Yield	0.50%	0.61%	-0.86%	-1.20%	-0.26%	-0.42%
Payout Ratio	38.17%	38.16%	-	-	123.52%	-
Buyback Yield / Dilution	7.59%	7.59%	2.53%	6.16%	-10.85%	0.91%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.